MFDS — authorised 31 July 2009
- Marketing authorisation holder: JANSSEN PHARMS
- Status: likely_approved
🇰🇷 Invega Sustenna in South Korea
MFDS authorised Invega Sustenna on 31 July 2009
Marketing authorisation
Invega Sustenna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Invega Sustenna approved in South Korea?
Yes. MFDS authorised it on 31 July 2009.
Who is the marketing authorisation holder for Invega Sustenna in South Korea?
JANSSEN PHARMS holds the South Korean marketing authorisation.